Josephine van Dongen

1 General introduction 19 book/rota.html 18. Anderson EJ,Weber SG. Rotavirus infection in adults. Lancet Infect Dis. 2004;4:91- 99. 19. DoorduynY, van Pelt W, Havelaar AH.The burden of infectious intestinal disease (IID) in the community: a survey of self-repor ted IID in The Netherlands. Epidemiol Infect. 2012;140(07):1185-1192. doi:10.1017/S0950268811001099 20. Hahné S, Hooiveld M,Vennema H, et al. Exceptionally low rotavirus incidence in the Netherlands in 2013/14 in the absence of rotavirus vaccination. Euro Surveill. 2014;19. 21. Van Gaalen RD,Van De Kassteele J, Hahné SJM, Bruijning-Verhagen P,Wallinga J. Determinants of rotavirus transmission: a lag non-linear time series analysis. Epidemiology. 2017;28(4):503-513. doi:10.1097/EDE.0000000000000654 22. NederlandseWerkgroep voor Klinische Virologie.Virologische weekstaten. Accessed in Feb 2020. https://www.rivm.nl/virologische-weekstaten/recente-virologie-uitslagen 23. Schurink-van t Klooster TM, de Melker HE.The National Immmunisation Programme in the Netherlands: Surveillance and developments. Natl Inst Public Heal Environ . Published online 2019:102-125. doi:10.1007/978-94-6265-282-8_2 24. Schurink-van t Klooster TM, de Melker HE.The National Immunisation Programme in the Netherlands - Surveillance and developments in 2019-2020. Natl Inst Public Heal Environ. Published online 2020. doi:10.21945/RIVM-2020-0077 25. Hungerford D, Cunliffe NA. Coronavirus disease (COVID-19) – impact on vac- cine preventable diseases. Eurosurveillance. 2020;25(18):1-2. doi:10.2807/1560-7917. ES.2020.25.18.2000756 26. Moerkamp AH., van Gool WA, Dutch Health Institute. Note of Dutch Health Coun- cil and Institute of Health by Advices on Vaccination against Rotavirus.; 2017. 27. Verhagen P, Moore D, Manges A, Quach C. Nosocomial rotavirus gastroenteritis in a Canadian paediatric hospital: Incidence, disease burden and patients affected. J Hosp Infect. Published online 2011. doi:10.1016/j.jhin.2011.04.020 28. Bruijning-Verhagen P, Mangen M-JJ, Felderhof M, et al.Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination. BMC Med . 2013;11(112). doi:10.1186/1741-7015-11-112 29. Chang H, Zhang L, GeY, et al. A Hospital-Based Case-Control Study of Diar- rhea in Children in Shanghai. Pediatr Infect Dis J. 2017;36(11):1057-1063. doi:10.1097/ INF.0000000000001562 30. Dennehy PH, Cor tese MM, Bégué RE, et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children. Pediatr Infect Dis J. 2006;25(12):1123-1131. doi:10.1097/01.inf.0000243777.01375.5b 31. Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal Risk Factors for In- fant HospitalizationWith Viral Gastroenteritis . Pediatrics. 2004;103(1):e3-e3. doi:10.1542/ peds.103.1.e3 32. Walther FJ, Bruggeman C, Daniels-Bosman MSM. Rotavirus infections in high-risk neonates. J Hosp Infect. 1984;(5):438-443. doi:10.1016/0195-6701(84)90014-8 33. Bányai K, Estes MK, Mar tella V, Parashar UD.Viral gastroenteritis. Lancet. 2018;392(10142):175-186. doi:10.1016/S0140-6736(18)31128-0 34. Bruijning-Verhagen P, Nipshagen MD, de Graaf H, Bonten MJM. Rotavirus disease course among immunocompromised patients; 5-year observations from a tertiary care medi- cal centre. J Infect. Published online August 2017. doi:10.1016/j.jinf.2017.08.006